NASDAQ$PGNY
Progyny Inc · Q2 2021 earnings
Q2 2021 earnings · · Investor relations
Briefing
Progyny had a solid second quarter, with strong topline growth and ongoing margin expansion.
Progyny reported a record second-quarter revenue of $128.7 million, reflecting a 99% increase compared to the previous year. The company's net income was $18.7 million, or $0.19 per diluted share, a significant increase from the net loss of $1.1 million in the second quarter of 2020. The company had 182 clients as of June 30, 2021, as compared to 134 clients as of June 30, 2020.
- Revenue was $128.7 million, a 99% increase as compared to the second quarter of 2020.
- Fertility benefit services revenue was $92.3 million, a 99% increase from the second quarter of 2020.
- Pharmacy benefit services revenue was $36.4 million, a 98% increase as compared to the second quarter of 2020.
- Net income was $18.7 million, or $0.19 income per diluted share, compared to a net loss of $1.1 million in the second quarter of 2020.
Headline financials
Revenue & EPS history
Progyny · Revenue · Quarterly
$129M
Revenue by segment
Progyny · $129M total across 2 segments · Q2 2021
- Fertility Benefit Services$92.3M+99.4%71.7%
- Pharmacy Benefit Services$36.4M+98.9%28.3%
Forward guidance
Progyny is providing financial guidance for the third quarter ending September 30, 2021, and the year ending December 31, 2021.
Historical earnings impact
How earnings announcements have historically affected this stock's price.
Avg. return before/after earnings
Based on 20 quarterly earnings reports · overlaid with Q2 2021
-1.1%
Avg return
Earnings day
-0.3%
Avg return
5 days after
-0.2%
Avg return
30 days after
38%
11 / 29 earnings
Positive
+26.4%
Q2 2022
Best reaction
-20.5%
Q4 2025
Worst reaction
| Quarter | Report date | Reaction (Day 0) | +5 days | +30 days |
|---|---|---|---|---|
| Q1 2026 | +2.5% | +25.4% | +38.2% | |
| Q4 2025 | -20.5% | -20.0% | -22.4% | |
| Q3 2025 | +24.3% | +33.6% | +33.4% | |
| Q1 2025 | -9.7% | -6.5% | -7.2% | |
| Q4 2024 | -1.5% | -5.2% | -4.3% | |
| Q3 2024 | -18.5% | -19.3% | -12.9% | |
| Q2 2024 | -17.7% | -14.7% | -6.4% | |
| Q1 2024 | -14.4% | -14.6% | -14.2% | |
| Q4 2023 | -13.1% | -9.7% | -4.3% | |
| Q3 2023 | -4.3% | -2.1% | +17.8% | |
| Q2 2023 | +4.9% | -2.8% | -8.6% | |
| Q1 2023 | +9.3% | +5.9% | +16.8% | |
| Q4 2022 | +22.9% | +18.4% | +7.7% | |
| Q3 2022 | -2.6% | +2.0% | -13.8% | |
| Q2 2022 | +26.4% | +25.5% | +15.4% | |
| Q1 2022 | -7.1% | -15.6% | -23.1% | |
| Q4 2021 | +11.5% | +13.0% | +31.6% | |
| Q3 2021 | +2.5% | +5.8% | -22.2% | |
| Q2 2021 | -12.8% | -17.1% | +4.3% | |
| Q1 2021 | -3.2% | -8.7% | +18.4% | |
| Q4 2020 | -15.5% | -14.9% | -14.4% | |
| Q3 2020 | -0.3% | +7.0% | +38.7% | |
| Q2 2020 | +0.4% | +8.4% | -0.9% | |
| Q1 2019 | -2.4% | +4.8% | -13.7% | |
| Q1 2020 | +21.8% | +18.8% | +2.1% | |
| Q4 2017 | -3.7% | -6.3% | -8.3% | |
| Q4 2019 | -12.2% | -15.5% | -39.0% | |
| Q4 2018 | -0.2% | -5.0% | -7.0% | |
| Q3 2019 | +0.5% | +0.3% | -6.5% | |
| Q2 2019 | — | — | — | |
| Q3 2018 | — | — | — | |
| Q2 2018 | — | — | — | |
| Q1 2018 | — | — | — |
Discussion
Share your read of this quarter. Sign-in carries your eToro identity.
Join the conversation
Sign in with eToro to post your read of this quarter and vote on others'.
Sign in with eToro